Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T16:11:02.240Z.
Consensus retrieved: 2026-10-06T09:28:17.274Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T16:11:02.240Z.
Quote observation: 2026-10-06T16:09:17.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: fe921af54d6420969180622b7fbdd7ef934f73e64ffcc47ddb287d73eacb5931
Forward PE Ratio (N/A) = Dated Quote Price ($1.47) / Consensus Forward EPS ($-0.63)
FORWARD PE RATIO
N/A
BioVie Inc.
Market Cap
$11.05M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| BioVie Inc. (BIVI) | $11.05M | N/A |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.93M | N/A |
| Cerenome, Inc. (CNSY)vs › | $11.19M | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.30M | N/A |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.77M | N/A |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.37M | N/A |
| Biofrontera Inc. (BFRI)vs › | $11.38M | N/A |
| Caring Brands, Inc. (CABR)vs › | $10.68M | N/A |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.44M | N/A |
| Polyrizon Ltd. (PLRZ)vs › | $10.64M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2027-06-30
At the dated quote price of $1.47, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2027-06-30 | $-0.63 | $-0.63 – $-0.63 | 1 | n/m |
| 2028-06-30 | $-0.57 | $-0.57 – $-0.57 | 1 | n/m |
| 2029-06-30 | $-0.55 | $-0.55 – $-0.55 | 1 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
